Search research articles
Contact Us
Filters
Showing results (121-130 of 186) with videos related to
Page
of 19
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 29, 2017
Pediatric Phase I Trial and Pharmacokinetic Study of Trebananib in Relapsed Solid Tumors, Including Primary Tumors of the Central Nervous System ADVL1115: A Children's Oncology Group Phase I Consortium Report
Sarah E S Leary, Julie R Park, Joel M Reid, et al.
Pediatric Blood & Cancer
|
April 26, 2018
A phase 1 study of cabozantinib in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1211, a report from the Children's Oncology Group
Meredith K Chuk, Brigitte C Widemann, Charles G Minard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 19, 2008
A phase I study of ABT-751, an orally bioavailable tubulin inhibitor, administered daily for 21 days every 28 days in pediatric patients with solid tumors
Elizabeth Fox, John M Maris, Brigitte C Widemann, et al.
Pediatric Blood & Cancer
|
August 8, 2023
Palbociclib in combination with chemotherapy in pediatric and young adult patients with relapsed/refractory acute lymphoblastic leukemia and lymphoma: A Children's Oncology Group study (AINV18P1)
Elizabeth A Raetz, David T Teachey, Charles Minard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2021
Activity of Crizotinib in Patients with ALK-Aberrant Relapsed/Refractory Neuroblastoma: A Children's Oncology Group Study (ADVL0912)
Jennifer H Foster, Stephan D Voss, David C Hall, et al.
Pediatric Blood & Cancer
|
May 3, 2018
A phase 1 study of eribulin mesylate (E7389), a novel microtubule-targeting chemotherapeutic agent, in children with refractory or recurrent solid tumors: A Children's Oncology Group Phase 1 Consortium study (ADVL1314)
Eric S Schafer, Rachel E Rau, Stacey Berg, et al.
JCO Clinical Cancer Informatics
|
April 10, 2026
Feasibility of Automated Laboratory Data Ascertainment and Transfer From Hospitals Into Medidata Rave Across Pediatric National Cancer Institute-Supported Cooperative Groups
Tamara P Miller, Richard Aplenc, Charles Minard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 25, 2025
Phase I Trial of Selinexor in Pediatric Recurrent/Refractory Solid and CNS Tumors (ADVL1414): A Children's Oncology Group Phase I Consortium Trial
Adam L Green, Charles G Minard, Xiaowei Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 10, 2010
A phase 1 trial and pharmacokinetic study of cediranib, an orally bioavailable pan-vascular endothelial growth factor receptor inhibitor, in children and adolescents with refractory solid tumors
Elizabeth Fox, Richard Aplenc, Rochelle Bagatell, et al.
Ecological Applications : a Publication of the Ecological Society of America
|
September 5, 2019
Fire-mediated habitat change regulates woodland bird species and functional group occurrence
Carl R Gosper, Simon J Watson, Elizabeth Fox, et al.
Page
of 19
Search research articles
Search
Showing results (121-130 of 186) with videos related to
Sort By:
Page
of 19
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 29, 2017
Pediatric Phase I Trial and Pharmacokinetic Study of Trebananib in Relapsed Solid Tumors, Including Primary Tumors of the Central Nervous System ADVL1115: A Children's Oncology Group Phase I Consortium Report
Sarah E S Leary, Julie R Park, Joel M Reid, et al.
Pediatric Blood & Cancer
|
April 26, 2018
A phase 1 study of cabozantinib in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1211, a report from the Children's Oncology Group
Meredith K Chuk, Brigitte C Widemann, Charles G Minard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 19, 2008
A phase I study of ABT-751, an orally bioavailable tubulin inhibitor, administered daily for 21 days every 28 days in pediatric patients with solid tumors
Elizabeth Fox, John M Maris, Brigitte C Widemann, et al.
Pediatric Blood & Cancer
|
August 8, 2023
Palbociclib in combination with chemotherapy in pediatric and young adult patients with relapsed/refractory acute lymphoblastic leukemia and lymphoma: A Children's Oncology Group study (AINV18P1)
Elizabeth A Raetz, David T Teachey, Charles Minard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2021
Activity of Crizotinib in Patients with ALK-Aberrant Relapsed/Refractory Neuroblastoma: A Children's Oncology Group Study (ADVL0912)
Jennifer H Foster, Stephan D Voss, David C Hall, et al.
Pediatric Blood & Cancer
|
May 3, 2018
A phase 1 study of eribulin mesylate (E7389), a novel microtubule-targeting chemotherapeutic agent, in children with refractory or recurrent solid tumors: A Children's Oncology Group Phase 1 Consortium study (ADVL1314)
Eric S Schafer, Rachel E Rau, Stacey Berg, et al.
JCO Clinical Cancer Informatics
|
April 10, 2026
Feasibility of Automated Laboratory Data Ascertainment and Transfer From Hospitals Into Medidata Rave Across Pediatric National Cancer Institute-Supported Cooperative Groups
Tamara P Miller, Richard Aplenc, Charles Minard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 25, 2025
Phase I Trial of Selinexor in Pediatric Recurrent/Refractory Solid and CNS Tumors (ADVL1414): A Children's Oncology Group Phase I Consortium Trial
Adam L Green, Charles G Minard, Xiaowei Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 10, 2010
A phase 1 trial and pharmacokinetic study of cediranib, an orally bioavailable pan-vascular endothelial growth factor receptor inhibitor, in children and adolescents with refractory solid tumors
Elizabeth Fox, Richard Aplenc, Rochelle Bagatell, et al.
Ecological Applications : a Publication of the Ecological Society of America
|
September 5, 2019
Fire-mediated habitat change regulates woodland bird species and functional group occurrence
Carl R Gosper, Simon J Watson, Elizabeth Fox, et al.
Page
of 19